The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer
Official Title: A Randomized, Open Label, Two Period, Single Dose, Crossover, Bioavailability Study of Paclitaxel Injection Concentrate for Suspension (PICS) in Subjects With Locally Recurrent or Metastatic Breast Cancer.
Study ID: NCT04332549
Brief Summary: A randomized, multi center, open label, two-period, single dose, crossover study to evaluate the bioavailability and safety of Paclitaxel Injection Concentrate for Suspension in Locally Recurrent or Metastatic Breast Cancer subjects.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
SPARC Site 12, Visakhapatnam, Andhra Pradesh, India
SPARC Site 21, Ahmadabad, Gujarat, India
SPARC Site 22, Sūrat, Gujarat, India
SPARC Site 4, Bangalore, Karnataka, India
SPARC Site 10, Bangalore, Karnataka, India
SPARC Site 18, Bangalore, Karnataka, India
SPARC Site 13, Bangalore, Karnataka, India
SPARC Site 9, Aurangabad, Maharashtra, India
SPARC Site 8, Kolhāpur, Maharashtra, India
SPARC Site 2, Nagpur, Maharashtra, India
SPARC Site 1, Nagpur, Maharashtra, India
SPARC Site 17, Nagpur, Maharashtra, India
SPARC Site 3, Nashik, Maharashtra, India
SPARC Site 19, Nashik, Maharashtra, India
SPARC Site 15, Pune, Maharashtra, India
SPARC Site 16, Pune, Maharashtra, India
SPARC Site 5, Pune, Maharashtra, India
SPARC Site 11, Sāngli, Maharashtra, India
SPARC Site 20, Khorda, Orissa, India
SPARC Site 14, Madurai, Tamil Nadu, India
SPARC Site 7, Lucknow, Uttar Pradesh, India
SPARC Site 6, Gujrat, Vadodara, India